Overview
EEC syndrome (Ectrodactyly-Ectodermal dysplasia-Cleft lip/palate syndrome) is a rare genetic disorder characterized by a triad of clinical features: ectrodactyly (split hand/foot malformation or lobster-claw deformity), ectodermal dysplasia, and facial clefting (cleft lip with or without cleft palate). The condition primarily affects structures derived from the ectoderm, including the skin, hair, nails, teeth, and sweat glands. EEC syndrome is most commonly caused by heterozygous mutations in the TP63 gene on chromosome 3q28, which encodes a transcription factor critical for ectodermal and limb development. The condition is also known as EEC3 (the most common form), and rarer forms have been mapped to other loci. The clinical presentation is highly variable, even within the same family. Ectrodactyly may range from mild syndactyly to severe split hand/foot deformities and can affect one or more limbs. Ectodermal dysplasia features include sparse, dry, and light-colored hair, thin and dystrophic nails, reduced sweating (hypohidrosis), and dental anomalies such as missing teeth (hypodontia) or small teeth (microdontia). Cleft lip and/or cleft palate occur in a significant proportion of affected individuals. Additional features may include lacrimal duct obstruction leading to chronic tearing and eye infections, urogenital anomalies (such as vesicoureteral reflux and hydronephrosis), conductive hearing loss, and photophobia due to blepharitis or keratitis. There is no cure for EEC syndrome, and management is multidisciplinary and symptom-based. Surgical repair of cleft lip/palate and limb malformations may be performed in infancy or childhood. Dental care, including prosthetic teeth, is often necessary. Ophthalmologic monitoring is important due to the risk of corneal complications. Dermatologic care for dry skin and management of hypohidrosis to prevent overheating are also recommended. Renal and urinary tract surveillance is advised given the risk of genitourinary anomalies. Genetic counseling is important for affected families due to the autosomal dominant inheritance pattern with variable expressivity and incomplete penetrance.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for EEC syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for EEC syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to EEC syndrome.
Community
No community posts yet. Be the first to share your experience with EEC syndrome.
Start the conversation →Latest news about EEC syndrome
No recent news articles for EEC syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about EEC syndrome
What is EEC syndrome?
EEC syndrome (Ectrodactyly-Ectodermal dysplasia-Cleft lip/palate syndrome) is a rare genetic disorder characterized by a triad of clinical features: ectrodactyly (split hand/foot malformation or lobster-claw deformity), ectodermal dysplasia, and facial clefting (cleft lip with or without cleft palate). The condition primarily affects structures derived from the ectoderm, including the skin, hair, nails, teeth, and sweat glands. EEC syndrome is most commonly caused by heterozygous mutations in the TP63 gene on chromosome 3q28, which encodes a transcription factor critical for ectodermal and lim
How is EEC syndrome inherited?
EEC syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does EEC syndrome typically begin?
Typical onset of EEC syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat EEC syndrome?
1 specialists and care centers treating EEC syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.